RA Capital Nexus Fund II, Director: Acumen Pharmaceuticals ABOS Buy · Filed 23/07/25

Trade details

Type: Insider buy
Amount: $39,999,997.5
Shares · price: 5,161,290 sh · $7.75 a share
Held after: 13,043,179 sh
Stock: Acumen Pharmaceuticals ABOS
Person: RA Capital Nexus Fund IIDirector
Trade date: 23/07/21
Filed: 23/07/25
Days to filing: 4 days

5 insiders bought this week

Insiders buying this week: 5 insiders
Holding change: +65.5%

Acumen Pharmaceuticals trades, last 26 weeks

What else happened in Acumen Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/06/21~23/08/20

RA Capital Nexus Fund II's recent trades

RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$45.7M
2,541,250 sh
$45.7M
Filed 05/06
Traded 05/04
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$2.4M
133,750 sh
$2.4M
Filed 05/06
Traded 05/04
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$2.1M
87,143 sh
$2.1M
Filed 05/06
Traded 05/05
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$1.3M
53,407 sh
$1.3M
Filed 05/06
Traded 05/06
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$347.3K
14,611 sh
$347.3K
Filed 05/06
Traded 05/06